{"id":513,"date":"2014-12-18T09:00:49","date_gmt":"2014-12-18T09:00:49","guid":{"rendered":"http:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/?p=513"},"modified":"2017-08-21T12:03:37","modified_gmt":"2017-08-21T12:03:37","slug":"primary-care-corner-with-geoffrey-modest-md-trigger-finger-injections","status":"publish","type":"post","link":"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/2014\/12\/18\/primary-care-corner-with-geoffrey-modest-md-trigger-finger-injections\/","title":{"rendered":"Primary Care Corner with Geoffrey Modest MD: Trigger Finger Injections"},"content":{"rendered":"<p>A study from Missouri assessed the longterm outcome of a single corticosteroid injection for a trigger finger (see\u00a0<strong>J Bone Joint Surg Am\u00a02014\u00a0Nov\u00a019;\u00a096:1849<\/strong>\u200b). They assessed 366 patients who had a first injection and followed a minimum of 5 years.<\/p>\n<p>Background:<\/p>\n<p>&#8211;Trigger fingers are\u00a0pretty common. lifetime risk estimated in general population of 2.6%, 4-10% in diabetics<\/p>\n<p>&#8211;And, from my patients, pretty uncomfortable and affects daily functioning<\/p>\n<p>Results:<\/p>\n<p style=\"padding-left: 30px\">&#8211;66% female, average age 59 yo,\u00a044% with multiple trigger fingers, 24% with diabetes.\u00a0majority had symptom of &#8220;catching&#8221; but able to actively extend the\u00a0digit\u200b.<\/p>\n<p style=\"padding-left: 30px\">&#8211;Their protocol was injecting the A1 pulley area with methylprednisolone 40mg\/cc, 1cc, and lidocaine without epinephrine 1%, 0.5 to 1 cc.<\/p>\n<p style=\"padding-left: 30px\">&#8211;Primary outcome (which was to\u00a0<strong>not<\/strong> get\u00a0subsequent injection or surgical release) of the affected digit was in 45% of patients, with a 56% success rate in females (vs 35% in males), and approx 38% in males and females with multiple trigger fingers.<\/p>\n<p style=\"padding-left: 30px\">&#8211;Of the treatment failures, 64% got another injection, 33% had surgical release<\/p>\n<p style=\"padding-left: 30px\">&#8211;84% of treatment failures were in the first 2 years after injection (ie, those who lasted 2 years did well longterm)<\/p>\n<p style=\"padding-left: 30px\">&#8211;Other studies have found even higher longish term\u00a0success rates (one with 92% for trigger thumbs, another with 72%)<\/p>\n<p>So, a few comments:<\/p>\n<p>&#8211;These are really easy injections. I use just 1\/2 cc of triamcinolone 40mg\/cc plus 1\/2 cc of lidocaine 1% and inject with a 30\u00a0gauge short needle (though it still hurts: thick skin and too many nerves), injecting where I palpate the nodule, which is right at the A1 pulley entrance, close to\u00a0the MCP joint on the volar surface). and, though I have not looked at the success rate rigorously, I am confident that in the dozens I\u00a0have injected, at least\u00a0\u00a090% have had really good responses and it is pretty rare that patients come back for more. and, even if the injection lasted\u00a0only 1 year, that&#8217;s a lot of relief for the patient, and re-injections (done rarely by me) have also been successful. \u00a0after 2 injections, I\u00a0would\u00a0suggest surgical intervention.<\/p>\n<p>&#8211;The injections take about 3 minutes and are the easiest of my patient visits (a thousand times easier than the more frequent patient with uncontrolled diabetes, hypertension, depression, domestic violence&#8230;&#8230;.). And, as an aside, an orthopedic surgeon doing this injection probably gets as much $$ as my health center collects for 5 visits\u00a0of my\u00a0more difficult\u00a0patients&#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Trigger Finger Injections  [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/2014\/12\/18\/primary-care-corner-with-geoffrey-modest-md-trigger-finger-injections\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":148,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[14283],"tags":[],"class_list":["post-513","post","type-post","status-publish","format-standard","hentry","category-archive"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/wp-json\/wp\/v2\/posts\/513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/wp-json\/wp\/v2\/users\/148"}],"replies":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/wp-json\/wp\/v2\/comments?post=513"}],"version-history":[{"count":0,"href":"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/wp-json\/wp\/v2\/posts\/513\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/wp-json\/wp\/v2\/media?parent=513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/wp-json\/wp\/v2\/categories?post=513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/bmjebmspotlight\/wp-json\/wp\/v2\/tags?post=513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}